一种罕见的呈现莱维拉塞坦诱导的Torsades De Pointes
Henry Mann1, Josef Kusayev2, Sagar Pandey1
1Internal Medicine, One Brooklyn Health System Interfaith Medical Center, Brooklyn, USA.
Cureus
|July 26, 2023
概括
莱维,一种抗药物,很少在患者中引起torsades de pointes和心脏骤停. 这一案例突出了与这种常见的处方药物相关的潜在心脏风险.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 尖的胸部是一个危及生命的心律失常,与延长的QTc间隔有关.
- 列维他是一种常见的抗药物,以其一般有利的安全性概况而闻名.
- 获得和先天性疾病可以导致QTc间隔延长.
研究的目的:
- 报告一个罕见的torsades de pointes病例和随后的心脏骤停在服用 levetiracetam 后.
- 为增加有关 levetiracetam 诱导的心律失常的有限文献做出贡献.
主要方法:
- 病例报告详细介绍了一名59岁男性患者的临床表现和不良事件.
- 审查病史和药物管理记录.
主要成果:
- 患者在接受 levetiracetam 后不久经历了torsades de pointes 和心脏骤停.
- 这代表了首个被记录的 levetiracetam 诱导的心脏骤停病例.
- 只有一个先前的病例报告存在,该病例报告将 levetiracetam 与torsades de pointes联系起来.
结论:
- 尽管有安全性概况,但甲可能与罕见但严重的心脏事件有关,如torsades de pointes和心脏骤停.
- 临床医生应该意识到这种潜在的不良影响,特别是在患有QTc延长风险因素的患者中.
- 需要进一步研究 levetiracetam 治疗心律失常的潜力.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
346
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
346
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
45
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
45
Antiepileptic Drugs: Potassium Channel Activators
214
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
214
Seizures: Classification
419
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
419
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.1K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.1K
Dysrhythmias II: Classification of Tachyarrhythmias
11
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
11


